[1]
Rizqiana Arum Sari, Habib Laksmana Prima, and Faishal Hanif, “Neuroprotective and Disease-Modifying Potential of GLP-1 Receptor Agonists in Parkinson’s Disease: A systematic Review of randomized Controlled Trials and Cohort Study”, IJHET, vol. 4, no. 5, Jan. 2026.